cyclophosphamide,prednisone,rituximab,polatuzumab vedotin,vincristine,doxorubicin
roche
['lymsm', 'pola', 'polarix']
to all trialists out there: check out this #17icml abstract by dr. . clinicians consistently underestimate incidence &amp; severity of patient-reported symptoms (these data are from polarix). we are not assessing "tolerability" unless we are analyzing pros! #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈